AAAAAA

   
Results: 1-10 |
Results: 10
The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin
Authors: Morganroth, J Hunt, T Dorr, MB Magner, D Talbot, GH
Citation: J. Morganroth et al., The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin, CLIN THER, 21(9), 1999, pp. 1514-1524
The cardiac pharmacodynamics of therapeutic doses of sparfloxacin
Authors: Morganroth, J Hunt, T Dorr, MB Magner, D Talbot, GH
Citation: J. Morganroth et al., The cardiac pharmacodynamics of therapeutic doses of sparfloxacin, CLIN THER, 21(7), 1999, pp. 1171-1181
Pharmacokinetics of sparfloxacin in patients with renal impairment
Authors: Dorr, MB Johnson, RD Jensen, B Magner, D Marbury, T Talbo, GH
Citation: Mb. Dorr et al., Pharmacokinetics of sparfloxacin in patients with renal impairment, CLIN THER, 21(7), 1999, pp. 1202-1215
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women
Authors: Henry, DC Nenad, RC Irvani, A Tice, AD Mansfield, DL Magner, DJ Dorr, MB Talbot, GH
Citation: Dc. Henry et al., Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women, CLIN THER, 21(6), 1999, pp. 966-981
Effects of food on the pharmacokinetics of sparfloxacin
Authors: Johnson, RD Dorr, MB Hunt, TL Jensen, BK Talbot, GH
Citation: Rd. Johnson et al., Effects of food on the pharmacokinetics of sparfloxacin, CLIN THER, 21(6), 1999, pp. 982-991
Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections
Authors: Dowzicky, M Nadler, H Dorr, MB Acusta, A Talbot, GH
Citation: M. Dowzicky et al., Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections, CLIN THER, 21(5), 1999, pp. 790-805
Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QT(c) interval)
Authors: Morganroth, J Talbot, GH Dorr, MB Johnson, RD Geary, W Magner, D
Citation: J. Morganroth et al., Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QT(c) interval), CLIN THER, 21(5), 1999, pp. 818-828
Pharmacokinetic interaction of sparfloxacin and digoxin
Authors: Johnson, RD Dorr, MB Hunt, TL Conway, S Talbot, GH
Citation: Rd. Johnson et al., Pharmacokinetic interaction of sparfloxacin and digoxin, CLIN THER, 21(2), 1999, pp. 368-379
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic
Authors: Lipsky, BA Dorr, MB Magner, DJ Talbot, GH
Citation: Ba. Lipsky et al., Safety profile of sparfloxacin, a new fluoroquinolone antibiotic, CLIN THER, 21(1), 1999, pp. 148-159
Effect of Maalox on the oral absorption of sparfloxacin
Authors: Johnson, RD Dorr, MB Talbot, GH Caille, G
Citation: Rd. Johnson et al., Effect of Maalox on the oral absorption of sparfloxacin, CLIN THER, 20(6), 1998, pp. 1149-1158
Risultati: 1-10 |